Cart
sales@molnova.com
GSK3-IN-2
CAS No. 380450-97-5
GSK3-IN-2( —— )
Catalog No. M36509 CAS No. 380450-97-5
GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 70 | In Stock |
|
| 10MG | 117 | In Stock |
|
| 25MG | 235 | In Stock |
|
| 50MG | 327 | In Stock |
|
| 100MG | 453 | In Stock |
|
| 200MG | 611 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK3-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
-
DescriptionGSK3-IN-2 (compound 8) is a potent GSK3 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number380450-97-5
-
Formula Weight313.42
-
Molecular FormulaC17H19N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(C3=C(NC2CC(C)(C)C1)NN=C3C)C=4C=CSC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Edward Scolnick, et al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1.
molnova catalog
related products
-
Sulfaphenazole
Sulfaphenazole is an inhibitor of CYP2C9 (Ki: 0.3 μM) that demonstrates at least 100-fold selectivity over other CYP450 isoforms (Ki: 63/29 μM for CYP2C8/CYP2C18, respectively, and no activity at CYP1A1, CYP1A2, CYP3A4, CYP2C19).
-
GSK-3β inhibitor 2
GSK-3β inhibitor 2 is a BBB-crossing and selective inhibitor of GSK-3β (IC50 = 1.1 nM). GSK-3β inhibitor 2 can be used in studies about Alzheimer's disease.
-
AR-A014418
A potent, specific ATP-competitive inhibitor of GSK-3β with Ki/IC50 of 38/104 nM.
